Hormone-Refractory Prostate Cancer Unknown Status Phase 2 Trials for Docetaxel (DB01248)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00795171Biomarker Study for Sunitinib and Docetaxel in Prostate CancerBasic Science